Prof. Dr. Bob van de Water is head of the Cancer Therapeutics and Drug Safety group at the Division of Drug Discovery & Safety.

Projects

• Oncogenic protein tyrosine kinases and Annexin family members in breast cancer formation and metastasis
• Live cell imaging-based modelling of cellular toxicity pathways
• Identification of novel druggable targets for estrogen-receptor positive and triple negative breast cancers
• Novel Anticancer Targets for Killing Drug Resistant Triple Negative Breast Cancer

Courses

• Theme Effects of drugs III – Drug Safety Evaluation
• Signal transduction: from target discovery to therapy
• Post Doctoral Course "Cell Toxicology"
• Post-Doctoral: "Cellular Toxicology/Predictive Toxicology" - IMI-SafeSciMET Training Programme in Safety Sciences